Imed Infinity Medical-Limited Partnership
Tel Aviv Stock Exchange IMED.TA
Imed Infinity Medical-Limited Partnership Price to Sales Ratio (P/S) on January 13, 2025
Imed Infinity Medical-Limited Partnership Price to Sales Ratio (P/S) is NA on January 13, 2025, a NA change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
-
Imed Infinity Medical-Limited Partnership 52-week high Price to Sales Ratio (P/S) is NA on January 13, 2025, which is NA below the current Price to Sales Ratio (P/S).
-
Imed Infinity Medical-Limited Partnership 52-week low Price to Sales Ratio (P/S) is NA on January 13, 2025, which is NA below the current Price to Sales Ratio (P/S).
-
Imed Infinity Medical-Limited Partnership average Price to Sales Ratio (P/S) for the last 52 weeks is NA.
Key data
| Date | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: IMED.TA
| CEO | Mr. Itay Gal-Or |
| IPO Date | Jan. 4, 2021 |
| Location | Israel |
| Headquarters | Azrieli Tower |
| Employees | 55 |
| Sector | Industrials |
| Industries | |
Description
Imed Infinity Medical-Limited Partnership, a research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field. The company was incorporated in 2020 and is based in Tel Aviv, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email